iBio
IBIO
$1.99
Share price
-1.97%
Change (1 day)
82.57%
Change (1 year)
Categories
EPS for iBio (IBIO)
EPS in 2023 (TTM): -$7.97
According to iBio's latest financial reports the company's current EPS (TTM) is -$7.97. In 2022 the company made an earnings per share (EPS) of -$8.84 a decrease over its 2021 EPS that were of -$3.39.
EPS history for iBio from 2008 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$7.97 | -9.84% |
| 2022 | -$8.84 | 160.57% |
| 2021 | -$3.39 | -22.74% |
| 2020 | -$4.39 | -86.98% |
| 2019 | -$33.75 | 10.66% |
| 2018 | -$30.50 | -31.07% |
| 2017 | -$44.25 | 26.43% |
| 2016 | -$35.00 | 55.56% |
| 2015 | -$22.50 | 12.5% |
| 2014 | -$20.00 | -11.11% |
| 2013 | -$22.50 | -40% |
| 2012 | -$37.50 | -11.76% |
| 2011 | -$42.50 | -57.5% |
| 2010 | -$100.00 | 300% |
| 2009 | -$25.00 | -15.58% |
| 2008 | -$29.61 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -276.64% | 🇺🇸 USA |
 Genocea Biosciences
GNCA | -$0.52 | -93.48% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -$1.63 | -79.56% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | -$12.08 | 51.49% | 🇺🇸 USA |